Cargando…

Are negative symptoms in schizophrenia a distinct therapeutic target?

BACKGROUND AND AIMS: The relationship between negative symptoms and cognition in schizophrenia is not clear, inconsistent findings have been reported by multiple authors and meta analyses. The aim of this study was to investigate the relationship between cognition and primary negative symptoms. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: CAPATINA, OCTAVIA OANA, MICLUTIA, IOANA VALENTINA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iuliu Hatieganu University of Medicine and Pharmacy 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808269/
https://www.ncbi.nlm.nih.gov/pubmed/29440953
http://dx.doi.org/10.15386/cjmed-864
_version_ 1783299437436600320
author CAPATINA, OCTAVIA OANA
MICLUTIA, IOANA VALENTINA
author_facet CAPATINA, OCTAVIA OANA
MICLUTIA, IOANA VALENTINA
author_sort CAPATINA, OCTAVIA OANA
collection PubMed
description BACKGROUND AND AIMS: The relationship between negative symptoms and cognition in schizophrenia is not clear, inconsistent findings have been reported by multiple authors and meta analyses. The aim of this study was to investigate the relationship between cognition and primary negative symptoms. METHODS: 67 outpatients diagnosed with schizophrenia were evaluated using PANSS and the NSA-16 scale. Correlation and regression analyses were used in the present study to investigate the relationship between the primary negative symptoms and cognition. RESULTS: No relationship was found between the PANSS Cognitive factor and Negative factor, but when investigating the relationship of the Cognitive PANSS factor with the negative symptoms evaluated with the NSA-16 scale, it was shown that there is a significant association between cognition and motor retardation. CONCLUSIONS: Our study reveals the relative independence of cognitive factor from the global negative domain of the psychopathology, even though the association with motor retardation was clear. These findings also support the need of using appropriate assessment tools in order to gain a more refined understanding of the phenomenology of schizophrenia.
format Online
Article
Text
id pubmed-5808269
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Iuliu Hatieganu University of Medicine and Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-58082692018-02-13 Are negative symptoms in schizophrenia a distinct therapeutic target? CAPATINA, OCTAVIA OANA MICLUTIA, IOANA VALENTINA Clujul Med Original Research BACKGROUND AND AIMS: The relationship between negative symptoms and cognition in schizophrenia is not clear, inconsistent findings have been reported by multiple authors and meta analyses. The aim of this study was to investigate the relationship between cognition and primary negative symptoms. METHODS: 67 outpatients diagnosed with schizophrenia were evaluated using PANSS and the NSA-16 scale. Correlation and regression analyses were used in the present study to investigate the relationship between the primary negative symptoms and cognition. RESULTS: No relationship was found between the PANSS Cognitive factor and Negative factor, but when investigating the relationship of the Cognitive PANSS factor with the negative symptoms evaluated with the NSA-16 scale, it was shown that there is a significant association between cognition and motor retardation. CONCLUSIONS: Our study reveals the relative independence of cognitive factor from the global negative domain of the psychopathology, even though the association with motor retardation was clear. These findings also support the need of using appropriate assessment tools in order to gain a more refined understanding of the phenomenology of schizophrenia. Iuliu Hatieganu University of Medicine and Pharmacy 2018 2018-01-15 /pmc/articles/PMC5808269/ /pubmed/29440953 http://dx.doi.org/10.15386/cjmed-864 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
spellingShingle Original Research
CAPATINA, OCTAVIA OANA
MICLUTIA, IOANA VALENTINA
Are negative symptoms in schizophrenia a distinct therapeutic target?
title Are negative symptoms in schizophrenia a distinct therapeutic target?
title_full Are negative symptoms in schizophrenia a distinct therapeutic target?
title_fullStr Are negative symptoms in schizophrenia a distinct therapeutic target?
title_full_unstemmed Are negative symptoms in schizophrenia a distinct therapeutic target?
title_short Are negative symptoms in schizophrenia a distinct therapeutic target?
title_sort are negative symptoms in schizophrenia a distinct therapeutic target?
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808269/
https://www.ncbi.nlm.nih.gov/pubmed/29440953
http://dx.doi.org/10.15386/cjmed-864
work_keys_str_mv AT capatinaoctaviaoana arenegativesymptomsinschizophreniaadistincttherapeutictarget
AT miclutiaioanavalentina arenegativesymptomsinschizophreniaadistincttherapeutictarget